Latest It Services News

Rox Resources reports strong underground progress and high-grade gold intercepts at Youanmi, reinforcing confidence in hitting production targets on schedule.

Hiremii Limited has delivered its most profitable quarter yet, reporting record revenue and gross profit alongside its first positive adjusted EBITDA. The company also secured its first recurring SaaS contracts, marking a milestone in its shift towards a technology-driven workforce intelligence model.

Cleanaway Waste Management has refreshed its long-term strategy, Blueprint 2030 2.0, focusing on leveraging scale, digitisation, and targeted growth to boost margins and cash flow. The plan builds on solid FY25 financial gains and aims for sustained EPS growth and operational efficiency.

HUB24 continued its strong growth trajectory in Q3 FY26 with $4 billion in net platform inflows and announced plans to acquire the trustee of its super fund, signaling strategic consolidation amid market volatility.

Blackpearl Group has reported a landmark $26.8 million in Annual Recurring Revenue (ARR) for Q4 FY26, marking a 114% year-on-year increase. With zero churn in its Data as a Service (DaaS) segment and improved customer acquisition efficiency, the company is now prioritising optimisation to accelerate cash flow and tighten customer profiles.

Rio Tinto (ASX: RIO) has updated details on its fully franked 2025 final dividend, confirming the dividend reinvestment plan (DRP) price and share allocation date. The USD 2.54 per share dividend is payable in multiple currencies with no discount applied to DRP shares.

Nutritional Growth Solutions (ASX: NGS) has completed a major operational reset, achieving normalised profitability, eliminating all debt, and replenishing inventory to support renewed growth.

AnteoTech (ASX: ADO) pushed forward its advanced battery and life sciences technologies in the March 2026 quarter, achieving key product validations and expanding its sales pipeline to record levels. The company ended the period with A$3.3 million cash and no debt following a recent A$3.5 million capital raise.

Lumos Diagnostics has secured a key FDA 510(k) clearance with CLIA waiver for its FebriDx rapid test, unlocking a US$1 billion-plus market opportunity and triggering milestone payments exceeding US$6 million. The company reported a 37% revenue jump in Q3 FY26, supported by a A$20 million placement and ongoing clinical and development projects.

4DMedical lands a contract with pharma giant GSK, gains UKCA certification for its CT:VQ™ lung imaging technology, and joins the S&P/ASX 200, marking a significant step in its global expansion.

ASX has successfully deployed Release 1 of its CHESS system, introducing a modern clearing platform designed to handle increased trading volumes and improve resilience. The rollout marks a key step in ASX's technology modernisation strategy, with Release 2 on track for 2029.

Emyria has unveiled the Empax Global Partnership Program, a high-margin clinical delivery platform targeting international drug sponsors amid growing demand for psychedelic-assisted mental health treatments.